Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Oncotelic Therapeutics, Inc. (OTLC) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Oncotelic Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 908259.
Total stock buying since 2016: $132,421.
Total stock sales since 2016: $0.
Total stock option exercises since 2016: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 545,581 | $10,703 | 0 | $0 | 0 | $0 |
| 2024 | 798,499 | $18,656 | 0 | $0 | 0 | $0 |
| 2023 | 1,226,888 | $35,489 | 0 | $0 | 0 | $0 |
| 2022 | 530,000 | $31,520 | 0 | $0 | 0 | $0 |
| 2020 | 135,673 | $25,613 | 0 | $0 | 0 | $0 |
| 2018 | 1,125,000 | $0 | 0 | $0 | 0 | $0 |
| 2016 | 30,000 | $10,440 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 198,737 | $993 | 0 | $0 | 0 | $0 |
| 2025-01 | 346,844 | $9,710 | 0 | $0 | 0 | $0 |
| 2024-11 | 298,499 | $8,656 | 0 | $0 | 0 | $0 |
| 2024-08 | 500,000 | $10,000 | 0 | $0 | 0 | $0 |
| 2023-06 | 1,000,000 | $26,675 | 0 | $0 | 0 | $0 |
| 2023-05 | 226,888 | $8,814 | 0 | $0 | 0 | $0 |
| 2022-12 | 360,000 | $18,000 | 0 | $0 | 0 | $0 |
| 2022-11 | 70,000 | $5,600 | 0 | $0 | 0 | $0 |
| 2022-09 | 20,000 | $1,360 | 0 | $0 | 0 | $0 |
| 2022-08 | 80,000 | $6,560 | 0 | $0 | 0 | $0 |
| 2020-11 | 132,673 | $25,253 | 0 | $0 | 0 | $0 |
| 2020-03 | 3,000 | $360 | 0 | $0 | 0 | $0 |
| 2018-04 | 1,125,000 | $0 | 0 | $0 | 0 | $0 |
| 2016-12 | 30,000 | $10,440 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-10 | Trieu Vuong (CHAIRMAN AND CEO) | Buy | 104,000 | .01 | 520 |
| 2025-07-09 | Trieu Vuong (CHAIRMAN AND CEO) | Buy | 1 | .01 | 0 |
| 2025-07-08 | Trieu Vuong (CHAIRMAN AND CEO) | Buy | 94,736 | .01 | 473 |
| 2025-01-31 | Trieu Vuong (CHAIRMAN AND CEO) | Buy | 63,775 | .03 | 1,785 |
| 2025-01-30 | Trieu Vuong (CHAIRMAN AND CEO) | Buy | 100,003 | .03 | 2,800 |
| 2025-01-29 | Trieu Vuong (CHAIRMAN AND CEO) | Buy | 183,066 | .03 | 5,125 |
| 2024-11-22 | Trieu Vuong (CHAIRMAN AND CEO) | Buy | 298,499 | .03 | 8,656 |
| 2024-08-23 | Trieu Vuong (CHAIRMAN AND CEO) | Buy | 500,000 | .02 | 10,000 |
| 2023-06-29 | Trieu Vuong (CHAIRMAN AND CEO) | Buy | 425,000 | .02 | 8,925 |
| 2023-06-28 | Trieu Vuong (CHAIRMAN AND CEO) | Buy | 75,000 | .03 | 1,950 |
| 2023-06-16 | Trieu Vuong (CHAIRMAN AND CEO) | Buy | 100,000 | .03 | 2,600 |
| 2023-06-14 | Trieu Vuong (CHAIRMAN AND CEO) | Buy | 400,000 | .03 | 13,200 |
| 2023-05-26 | Trieu Vuong (CHAIRMAN AND CEO) | Buy | 126,888 | .03 | 4,314 |
| 2023-05-02 | Trieu Vuong (CHAIRMAN AND CEO) | Buy | 100,000 | .04 | 4,500 |
| 2022-12-06 | Trieu Vuong (CHAIRMAN AND CEO) | Buy | 240,000 | .05 | 12,000 |
| 2022-11-22 | Trieu Vuong (CHAIRMAN AND CEO) | Buy | 70,000 | .08 | 5,600 |
| 2022-09-26 | Trieu Vuong (CHAIRMAN AND CEO) | Buy | 20,000 | .07 | 1,360 |
| 2022-08-25 | Trieu Vuong (CHAIRMAN AND CEO) | Buy | 80,000 | .08 | 6,560 |
| 2020-11-24 | Shah Amit B. (CHIEF FINANCIAL OFFICER) | Buy | 8,220 | .19 | 1,561 |
| 2020-11-23 | Shah Amit B. (CHIEF FINANCIAL OFFICER) | Buy | 20,088 | .19 | 3,816 |
| 2020-11-20 | Shah Amit B. (CHIEF FINANCIAL OFFICER) | Buy | 31,692 | .20 | 6,179 |
| 2020-11-19 | Park Chulho (CHIEF TECHNOLOGY OFFICER) | Buy | 22,173 | .18 | 4,102 |
| 2020-11-19 | Trieu Vuong (CHIEF EXECUTIVE OFFICER) | Buy | 50,500 | .19 | 9,595 |
| 2020-03-26 | Trieu Vuong (CHIEF EXECUTIVE OFFICER) | Buy | 3,000 | .12 | 360 |
| 2018-04-12 | Reynolds Donald Rogers (Director) | Buy | 250,000 | .00 | 0 |
| 2018-04-12 | Schwieterman William D (President and CEO) | Buy | 625,000 | .00 | 0 |
| 2018-04-12 | Loar Matthew M (Chief Financial Officer) | Buy | 250,000 | .00 | 0 |
| 2016-12-16 | Reynolds Donald Rogers (Director) | Buy | 30,000 | .35 | 10,440 |
Insider trading activities including stock purchases, stock sales, and option exercises of OTLC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Oncotelic Therapeutics, Inc. (symbol OTLC, CIK number 908259) see the Securities and Exchange Commission (SEC) website.